References

  1. Hruska KA, Teitelbaum SL. Renal osteodystrophy. 
N Engl J Med 1995;333:166-174.

  2. Wang M, Hercz G, Sherrard, et al. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. Am J Kidney Dis 1995;26:836-844.

  3. Bonomini V, Feletti C, Di Felice A, Buscaroli A. Bone remodelling after renal transplantation (RT). Adv Exp Med Bio 1984;17:207-216.

  4. Sanchez CP, Salusky IB, Kuizon BD, et al. Bone disease in children and adolescents undergoing successful renal transplantation. Kidney Int 1998;53:1358-1364.

  5. Parfitt AM: Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab 1982;8:92-112.

  6. Julian BA, Laskow DA, Dubovsky J, et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991;325:544-550.

  7. Velasquez-Forero F, Mondragón A. Herrero B, Peña JC. Adynamic bone lesion in renal transplant recipients with normal renal function. Nephrol Dial Transplant 1996;11 Suppl 3:58-64.

  8. Carlini RG, et al.: What are the bone lesions in patients with more than four years of a functioning renal transplant? Nephrol Dial Transplant 1998;13 Suppl 3:103-104.

  9. Monier-Faugere MC, Mawad H, Qi Q, et al.High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 2000;11:1093-1099.

  10. Cruz EA, Lugon JR, Jogetti V, et al. Histologic evolution of bone disease 6 months after successful kidney transplantation. Am J Kidney Dis 2004;44:747-756.

  11. Lehmann G, et al.: Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients. Transplant Proc 2007;39:3153-3158.

  12. Rojas E, Carlini RG, Clesca P, et al The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int 2003;63:1915-1923.

  13. Mikuls TR, Julian BA, Bartolucci A, Saag KG. Bone mineral density changes within six months of renal transplantation. Transplantation 2003;75:49-54.

  14. Brandenburg VM, et al.: Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation. Transplantation 2004;77:1566-1571.

  15. Cruz DN, Wysolmerski JJ, Brickel HM, et al. Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study. Transplantation 2001;72:83-88.

  16. Ball AM, Gillen DL, Sherrard D, et al. Risk of hip fracture among dialysis and renal transplant recipients. JAMA 2002;288:3014-3018.

  17. Vautour LM, Melton LJ 3rd, Clarke BL, et al. Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 2004;15:160-167.

  18. Malluche HH, Lee J, Wang G, et al. Usefulness of the new TMV classification of renal osteodystrophy. J Am Soc Nephrol 2008;19:38A. Abstract presented at Kidney Week 2008.

  19. Moe S, Drüeke T, Cunningham J, et al.Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006;69:1945-1953.

  20. Epstein S. Post-transplantation bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 1996;11:1-7.

  21. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352-364.

  22. Ugur A, Guvener N, Işiklar I, et al. Osteoporosis after renal transplantation: single center experience. Transplantation 2001;71:645-649.

  23. Marcén R, Caballero C, Pascual J, et al. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study. Transplantation 2006;81:826-831.

  24. Patel S, Kwan JT, McCloskey E, et al. Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res 2001;16:1863-1870.

  25. Singha UK, Jiang Y, Yu S, et al.Rapamycin inhibits osteoblast proliferation and differentiation in MC3T3-E1 cells and primary mouse bone marrow stromal cells. J Cell Biochem 2008;103:434-446.

  26. Kneissel M, Luong-Nguyen NH, Baptist M, et al. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts. Bone 2004;35:1144-1156.

  27. Ambrus C, Molnar MZ, Czira ME, et al. Calcium, phosphate and parathyroid metabolism in kidney transplanted patients. Int Urol Nephrol 2009;41:1029-1038.

  28. Akaberi S, Lindergård B, Simonsen O, Myberg G. Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function. Transplantation 2006;82:749-752.

  29. van den Ham EC, Kooman JP, Christiaans ML, van Hooff JP. The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients. Transpl Int 2003;16:82-87.

  30. Coco M, Glicklich D, Faugere MC, et al. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. 
J Am Soc Nephrol 2003;14:2669-2676.

  31. Nowacka-Cieciura E, Cieciura T, Baczkowska T, et al. Bisphosphonates are effective prophylactic of early bone loss after renal transplantation. Transplant Proc 2006;38:165-167.

  32. Grotz W, Nagel C, Poeschel D, et al. Effect of ­ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 2001;12:1530-1537.

  33. Haas M, Leko-Mohr Z, Roschger P, et al.Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation. Kidney Int 2003;63:1130-1136.

  34. Torregrosa JV, Fuster D, Gentil MA, et al. Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipients. Transplantation 2010;89:1476-1481.

  35. Schwarz C, Mitterbauer C, Heinze G, et al. Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantation. Kidney Int 2004;65:304-309.

  36. Palmer SC, McGregor DO, Strippoli GF. Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev. 2007;18:CD005015.

  37. Josephson MA, Schumm LP, Chiu MY, et al. 
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. Transplantation 2004;
78:1233-1236.

  38. Torres A, Garcia S, Gómez A, et al.Treatment with intermittent calcitriol and calcium reduces bone 
loss after renal transplantation. Kidney Int 2004;65:705-712.

  39. De Sevaux RG, et al.: Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J Am Soc Nephrol 2002;13:1608-1614.

  40. Perez V, Sánchez A, Bayés B, et al. Effect of 
paricalcitol on the urinary peptidome of 
kidney transplant patients. Transplant Proc 2010;42:2924-2927.

  41. Bergua C, Torregrosa JV, Fuster D, et al. Effect of cinacalcet on hypercalcemia and bone mineral 
density in renal transplanted patients with secondary hyperparathyroidism. Transplantation 2008;86:
413-417.

  42. Cejka D, Benesch T, Krestan C, et al. Effect of teriparatide on early bone loss after kidney transplantation. Am J Transplant 2008;8:1864-1870.